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Why was the cohort set up?
Understanding the effects of SARS-CoV-2 infection on mater-
nal, pregnancy and neonatal health is essential to inform pub-
lic health policy.1 The epidemiology of COVID-19 in
pregnancy remains incompletely understood as, to date, most
studies have included selected cohorts of pregnant women
who have required treatment for COVID-19 rather than
population-based data.2–5 SARS-CoV-2 transmission from
mother to baby (antenatally or intrapartum) appears to be
possible, but the proportion of pregnancies affected and its
clinical significance are uncertain.6,7 Potential effects of the vi-
rus on early pregnancy losses, congenital anomalies and fetal
growth remain largely un-investigated, and studies have
reported conflicting findings on associations between COVID-
19 and late miscarriage, preterm birth and stillbirth.2,7
Understanding the effects of COVID-19 in pregnancy
and perinatally at different stages will help inform policy
and advice to pregnant women and those considering preg-
nancy, and will provide a platform for studies of long-term
effects. It is also essential to inform immunization strate-
gies via assessing the safety and effectiveness of vaccination
in pregnancy. Pregnant women have been largely excluded
from clinical trials of COVID-19 vaccines, thus despite
pregnant women being considered as a vulnerable group, it
was initially unclear whether vaccination should be offered
to pregnant women,8–10 This early lack of clarity regarding
vaccine recommendations to pregnant women has contrib-
uted to low uptake of COVID-19 vaccination in this
group, despite evidence of vaccine effectiveness and safety
from observational studies.8–10
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COPS11 is a sub-study of the EAVE II cohort (Early
Pandemic Evaluation and Enhanced Surveillance of
COVID-19), an observational study using linked Scottish
national data,12–17 funded by the Medical Research
Council and Scottish Government Director-General for
Health and Social Care, Tommy’s Charity and the
Wellcome Trust. An overview of the cohort is provided in
Figure 1.
Who is in the cohort?
COPS is a sub-study of EAVE II using unconsented data,
which is covered by National Research Ethics Service
Committee, South East Scotland 02 approval reference
REC 12/SS/0201: SA 2. COPS has been approved by the
Public Benefit and Privacy Panel approval reference 2021–
0116. Public Health Scotland and the Chief Medical
Officer for Scotland are both (independent) data control-
lers for the national Abortion Act Scotland (AAS) database
of termination of pregnancy notifications; thus the Chief
Medical Officer has been informed of the use of AAS
records for this study and permission to access to the AAS
database was granted. All permissions to link the datasets
were received by 31 August 2020.
COPS is a national dynamic cohort of all women who
were pregnant on, or became pregnant after, 1 March
2020.11 Ongoing pregnancies are identified from antenatal
booking records. Completed pregnancies are identified
from general and maternity hospital discharge records,
general practitioner (GP) records, statutory termination of
pregnancy records and statutory live and stillbirth registra-
tions (see Table 1 for an overview of data sources; a more
detailed description of how the pregnancy cohort was set
up is available in Supplementary material, available at IJE
online). Hospital and GP records capture women who
have early pregnancy losses (miscarriage, molar pregnancy
or ectopic pregnancy) and receive care from a health care
provider. Women who had a very early pregnancy loss and
who do not attend or notify their GP or attend hospital for
care will not be included. However, we anticipate that
these numbers will be small, as, in Scotland: (i) the
National Health Service (NHS) provides free health care to
all women; (ii) pregnant women are advised to see their GP
or attend an early pregnancy unit if they have any signs of
a miscarriage; and (iii) clinicians and miscarriage support
groups have informed us that only a small minority of
women have a miscarriage and do not seek care.28,35,36 As
statutory birth records are used, we capture all births in-
cluding home births (<2% of births in Scotland), although
clinical maternity data may be missing for a proportion of
home births. There are no private obstetric services in
Scotland.
The cohort is updated monthly, allowing near ‘real-
time’ identification of pregnant and recently pregnant
women. There are differences in source data latency to the
unified COPS dataset (see Supplementary material), which
means that data for the most recent months are most un-
stable, with potential for missing conceptions and end-of-
pregnancy events; initial findings may be ‘overruled’ over
time as more detailed records accrue. Data are generally
complete for conceptions and end-of-pregnancy events oc-
curring up to 3–4 months previously.
As of 16 September 2021, the cohort included 123 004
women with 134 070 completed or ongoing pregnancies.
We have completed pregnancy outcomes for the first wave
COVID-19 cohort, which included women who were preg-
nant on the 1 March 2020 and those who became pregnant
up to 30 June 2020 (n¼ 60 402 pregnancies). The cohort
continues to be updated and the end date depends on the
course of the pandemic and requirement to support future
pandemic preparedness.
Key Features
• COVID-19 in Pregnancy in Scotland (COPS) is a new national prospective dynamic cohort that was created to
describe the epidemiology of COVID-19 in pregnancy and the effect of SARS-CoV-2 infection on pregnancy outcomes
and to investigate the safety and effectiveness of COVID-19 vaccines among pregnant women.
• The cohort links primary care records to maternity records, national birth and mortality records and other secondary
health care data, together with laboratory results and vaccination information, thus providing a robust platform for
the study of viral effects and pharmacoepidemiological research.
• As of 16 September 2021, the dynamic cohort included 123 004 women with 134 070 completed or ongoing
pregnancies. Pre-pandemic outcome rates for analyses can be calculated from an approved retrospective extension
of the cohort to 1 January 2015.
• Data are hosted in the Public Health Scotland’s (PHS) trusted research environment (TRE) and access may be granted
via an enquiry to [phs.edris@phs.scot].
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How often have they been followed up?
Data are collected from women throughout their pregnancy
to 41 days postpartum, and data on their babies are collected
up to the end of the neonatal period (27 days after birth).
Women enter the cohort on identification of a preg-
nancy from one or more sources of routinely collected
health care data from primary and secondary care settings
(see Table 1). Pregnancy outcome (i.e. ectopic pregnancy,
molar pregnancy, miscarriage, termination of pregnancy,
stillbirth or live birth) is obtained from the same datasets,
and data are linked to a number of other sources (also sum-
marized in Table 1) to investigate maternal demographics
and comorbidities. Further information on fetal and neo-
natal outcomes [congenital anomaly, preterm birth, very
preterm birth, small for gestational age, severe small for
gestational age, microcephaly, severe microcephaly, low
Apgar score, very low Apgar score, neonatal SARS-CoV-2
infection (see Supplementary Table S1, available as
Supplementary data at IJE online, for definitions), neona-
tal mortality and extended perinatal mortality)] and mater-
nal outcomes [COVID-19 disease, severe COVID-19
disease (see Supplementary Table S1 for definitions), any
maternal death, thromboembolic disease, hypertensive dis-
orders of pregnancy] also come from the same datasets.
New pregnant women are added to the cohort and new
outcomes are identified at monthly updates. Women who
have given birth, and their babies, remain in the cohort.
Pregnant women who leave Scotland before pregnancy end
will have the pregnancy outcome recorded as unknown,
but will remain in the cohort. Linkage through a universal
health care identifier (Community Healthcare Index or
CHI) will allow further follow-up of women and children
unless they leave Scotland permanently.
What has been measured?
The data sources provide comprehensive information on
pregnancy and maternal and neonatal outcomes, as well as
complications, pre-existing and pregnancy risk factors,
clinical vulnerability to COVID-19, COVID-19 diagnosis
and vaccination status. An overview of the maternal and
pregnancy characteristics and pregnancy and neonatal out-
come data that are collected are in Table 2. A high-level
summary of other key exposure and outcome data being
collected is provided in Supplementary Table S1. Detailed
description and definitions of outcomes can be found in
the COPS data dictionary.37
What has it found?
There were 38 106 ongoing pregnancies in Scotland on 1
March 2020. As of the 16 September 2021, data on a
Figure 1 Overview of the creation of the COPS cohort. CHI, Community Health Index; COVID, COVID-19 [coronavirus disease 2019]; ICU, intensive
care unit; COPS, COVID-19 in pregnancy in Scotland
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Table 1 Data sources used to generate the COVID-19 in Pregnancy in Scotland (COPS) cohort
Data source Description
Identification of pregnant women, associated pregnancy start/end dates, and maternal, pregnancy and neonatal outcomes
Antenatal booking records A national data return developed as part of the response to the COVID-19 pandemic, provid-
ing information on all women booking for antenatal care with National Health Service
(NHS) maternity services throughout Scotland. More than 99% of women who give birth in
Scotland book for antenatal care with NHS maternity services
Use: identification of women with ongoing pregnancies in near-real time
General practioner (GP) record data A bespoke data feed from all GP practices in Scotland containing information on women who
have miscarriage, ectopic pregnancy and molar pregnancy
Use: identification of women with early miscarriage, molar pregnancy or ectopic pregnancy
not admitted to hospital (i.e. those cared for by their GP and those receiving outpatient/day
patient care in a hospital setting such as an early pregnancy centre)
Scottish Morbidity Record (SMR)
0118
The SMR01 database includes all general day case and inpatient admissions in Scotland.
Admissions to neonatal, maternity and mental health care are excluded from SMR01 as they
are covered by other specialist datasets
Use: identification of women with early miscarriage, molar pregnancy or ectopic pregnancy ad-
mitted to hospital
Abortion Act Scotland (AAS)
records19
Statutory notifications of termination of pregnancy, including those indicated by congenital
anomaly
Use: identification of women who have termination of pregnancy
Scottish Morbidity Record (SMR)
0220
The SMR02 database includes all day case and inpatient admissions to maternity specialties in
Scotland
Use: identification of miscarriage, stillbirth and live births managed in hospital (98% of
births in Scotland) and some home births (2% of births in Scotland), some ectopic, molar
and terminations of pregnancy cared for in maternity settings
National Records of Scotland (NRS)
statutory stillbirth registrations21
Scottish legislation requires all stillbirths at 24 weeks of gestation or more to be registered with
NRS within 21 days of birth
Use: identification of stillbirths
National Records of Scotland (NRS)
statutory live birth registrations22
Scottish legislation requires all live births at any gestation to be registered with NRS within
21 days of birth
Use: identification of live births
NHS Live Births New national data return developed as part of the response to the COVID-19 pandemic, pro-
viding information on live births notified by maternity services to NHS Board child health
administrative departments: for near-real time access to data, which allows intergenerational
linkage of records relating to mothers and their babies if statutory live birth registration is
suspended
Use: identification of livebirths
Scottish Intensive Care Society Audit
Group (SICSAG) records23
National database of patients admitted to adult general critical care units in Scotland, detailing
information on the management of critically ill or injured patients. All general intensive care
units and combined ICU/high dependency units (HDU) collect data and more than 90% of
general high dependency units and a number of specialist ICU and HDUs also provide
records
Use: identification of women admitted to intensive care
Scottish Birth Record (SBR)24 The SBR records basic demographic data on all births in Scotland and additional clinical infor-
mation and diagnostic and operational procedure codes on babies admitted to neonatal care
Use: identification of neonates admitted to neonatal care
Scottish linked congenital anomaly
database25
National database of congenital anomalies with data derived from SMR02, SMR01, AAS,
SBR, NRS statutory stillbirth and death registration and Mothers and Babies: Reducing Risk
through Audits and Confidential Enquiries across the UK (MBRRACE-UK) records
Use: identification of babies with congenital anomalies and classification of congenital
anomaly
(Continued)
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further 95 964 pregnancies conceived from 1 March 2020
onwards have been added to the cohort. The COVID-19
first wave cohort, with women who were pregnant on 1
March 2020 or who subsequently became pregnant up un-
til 30 June 2020, includes a total of 60 402 pregnancies.
Figure 2 shows gestational age distribution of ongoing
pregnancies on 1 March 2020 (panel a) and the concep-
tions each month from 1 March 2020 onwards (panel b).
Figure 3 shows the outcomes of all pregnancies in the dy-
namic cohort by month of conception. Maternal
Table 1 Continued
Data source Description
Identification of women with confirmed or suspected COVID-19
Electronic Communication of
Surveillance in Scotland (ECOSS)26
and other virology results held sepa-
rately by Public Health Scotland
(PHS)
ECOSS is a database that holds surveillance data on various microorganisms (e.g. influenza vi-
rus, coronavirus) and infections reported from NHS diagnostic and reference laboratories
and Pillar 2 facilities/Lighthouse laboratories [high-throughput facilities dedicated to
COVID-19 viral Reverse Transcription-Polymerase Chain Reaction (RT-PCR) testing for the
National Testing Programme]. Data on laboratory results for all SARS-CoV-2 RT-PCR tests
carried out in Scotland are being collated by ECOSS and can be linked to other data sources
Use: identification of women and neonates with viral RT-PCR tests for SARS-CoV-2
National Records of Scotland (NRS)
statutory death registrations27
National statutory death records
Use: identification of women with COVID-19 recorded as cause of death
SMR0118, SMR0220 and NRS
stillbirths21
As described above
Use: identification of women with COVID-19 recorded as cause of admission/stillbirth
Identification of treatments, vaccination status and risk group
Early Pandemic Evaluation and
Enhanced Surveillance of COVID-
19
(EAVE II) cohort
An extract of current and past diagnoses from the EAVEII cohort,28 which is based on all 5.4
million individuals registered with a GP in Scotland from 23 February 2020 (98–99% of the
Scottish population)
Use: identification of comorbidities and COVID-19 risk grouping (using the QCOVID29 risk
grouping plus hypertension)
Shielding list Public Health Scotland list drawn from a number of data sources including those thought to be
extremely clinically vulnerable
Use: identification of extremely clinically vulnerable pregnant women
Vaccine Management Tool (VMT)
records30
The Turas VMT is a new application that has been developed by NHS Education for Scotland
to record delivery of COVID-19 vaccination in different NHS and community settings
Use: identification of vaccination and vaccination date
GP vaccination data An extract from GP records with data on vaccinations administered in practices that are not
using the VMT
Use: identification of vaccination and vaccination date
Health care worker records: Scottish
Workforce Information Standard
System (SWISSþ)31
A new national health care worker (HCW) dataset to support analyses relating to COVID-19
in this occupational group. The HCW data within the dataset are derived from an extract of
the SWISS system with information of staff directly employed by the NHS and GPs con-
tracted to provide NHS care
Use: identification of women eligible for vaccination due to health care worker status
Child Health Systems Program
(CHSP) – Pre-school (PS)32
The CHSP-PS system supports the delivery of the child health programme by facilitating the
automated call and recall of children for the agreed schedule of child health reviews for pre-
school children
Use: infant feeding records to identify women vaccinated during breastfeeding
Additional data sets with governance approval for future linkage
Serology databases Residual sera from blood tests taken for combined first trimester screening for fetal trisomies
such as Down’s syndrome, offered as part of routine antenatal care, are being tested for
SARS-CoV-2 antibodies as part of the surveillance of the pandemic in Scotland
Proposed use: identification of women with serological evidence of infection and vaccination
Community prescribing [PIS]
records33
This includes information on all prescribed medications that are dispensed in the community
in Scotland




Electronic records of hospital-administered treatments, currently available within four Scottish
hospitals
Proposed use: identification of COVID-19 treatments given
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Table 2 Maternal characteristics and key pregnancy and neonatal outcomes of the dynamic COVID-19 in Pregnancy in Scotland
(COPS) (up to mid-September 2021) and first wave cohort (women who were pregnant on 1 March 2020 or who became preg-
nant between 1 March 2020 and 30 June 2020)
COPS dynamic cohort
(as of 16 September 2021)
COPS COVID-19 first wave cohort
(pregnancies from 1 March
to 30 June 2020)
Number of women 123 004 59 926
Number of pregnancies 134 070 60 402






19 years 6331 4.7 2782 4.6
20–24 years 20 742 15.5 9400 15.6
25–29 years 36 956 27.6 17 037 28.2
30–34 years 41 749 31.1 18 964 31.4
35–39 years 22 675 16.9 9948 16.5
40–44 years 4997 3.7 2070 3.4
45 years 350 0.3 140 0.2
Unknown1 270 0.2 61 0.1
Deprivation level (Scottish Index of
Multiple Deprivation (SIMD) quintile)
1 (most deprived) 32 514 24.3 14 593 24.2
2 27 800 20.7 12 406 20.5
3 24 185 18.0 10 925 18.1
4 26 580 19.8 12 156 20.1
5 (least deprived) 22 128 16.5 10 066 16.7
Unknown 863 0.6 256 0.4
Self-reported ethnicity
Black/Caribbean/African 1801 1.3 921 1.5
Chinese 636 0.5 341 0.6
Mixed or other ethnic group 3894 2.9 1977 3.3
South Asian 3903 2.9 1970 3.3
White 94 230 70.3 47 199 78.1
Unknown 29 606 22.1 7994 13.2
NHS Board of Residence
Ayrshire and Arran 8108 6.0 3658 6.1
Borders 2194 1.6 1015 1.7
Dumfries and Galloway 3004 2.2 1431 2.4
Fife 8812 6.6 3956 6.5
Forth Valley 7290 5.4 3275 5.4
Grampian 14 256 10.6 6465 10.7
Greater Glasgow and Clyde 29 965 22.4 13 618 22.5
Highland 6621 4.9 3022 5.0
Lanarkshire 17 678 13.2 7784 12.9
Lothian 23 983 17.9 10 833 17.9
Orkney 448 0.3 212 0.4
Shetland 479 0.4 223 0.4
Tayside 9831 7.3 4425 7.3
Western Isles 468 0.3 209 0.3
Outside Scotland 18 0.0 2 0.0
Unknown 915 0.7 274 0.5
(Continued)
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Table 2 Continued
COPS dynamic cohort
(as of 16 September 2021)
COPS COVID-19 first wave cohort
(pregnancies from 1 March
to 30 June 2020)
Maternal urban/rural classification
Very remote rural areas 1642 1.4 903 1.5
Very remote small towns 868 0.8 466 0.8
Remote rural areas 2160 1.9 1168 1.9
Remote small towns 2142 1.9 1164 1.9
Accessible rural areas 10 288 9.0 5593 9.2
Accessible small towns 7564 6.6 4038 6.7
Other urban areas 34 259 29.8 18 281 30.2
Large urban areas 38 724 33.7 20 487 33.8
Unknown 17 249 15.0 8490 14.0
Maternal body mass index (BMI; kg/m2)
at pregnancy booking or pre-pregnancy
<18.5 3092 2.3 1587 2.6
18.5–<25 39 113 29.2 20 697 34.3
25–<30 29 731 22.2 15 920 26.4
30–40 22 803 17.0 12 231 20.2
40 4242 3.2 2223 3.7
Unknown 35 089 26.2 7744 12.8
Smoking status at pregnancy booking
Current smoker 13 272 9.9 6706 11.1
Former smoker 15 205 11.3 7450 12.3
Never smoker 77 537 57.8 37 225 61.6
Unknown 28 056 20.9 9021 14.9
Clinical vulnerability group
Clinically extremely vulnerable risk
group status2
1119 0.8 572 0.9
Clinically vulnerable risk group status3 35 364 26.4 15 996 26.5
No clinical vulnerable group identified 97 587 72.8 43 834 72.6
Plurality
Singleton pregnancy 71 828 53.6 48 365 80.1
Multiple pregnancy 1078 0.8 709 1.2
Unknown 61 164 45.6 11 328 18.8
Gestation at end of pregnancy
12 weeks 28 909 21.6 8848 14.6
13–23 weeks 2787 2.1 1144 1.9
24–27 weeks 396 0.3 210 0.3
28–31 weeks 615 0.5 358 0.6
32–36 weeks 4416 3.3 2790 4.6
37–41 weeks 63 999 47.7 43 959 72.8
42 weeks 4421 3.3 3093 5.1
Pregnancy ongoing 28527 21.3 0 –
n % of completed pregnancies
(n ¼ 105 543)
n % of completed
pregnancies
Pregnancy outcome
Miscarriage4 11 733 11.1 3563 5.9
Ectopic pregnancy 1108 1.0 300 0.5
Termination 18 533 17.6 6013 10.0
Stillbirth 243 0.2 158 0.3
Live birth 70 538 66.8 48 151 79.7
Unknown 3388 27.0 2406 4.0
(Continued)
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Table 2 Continued
COPS dynamic cohort
(as of 16 September 2021)
COPS COVID-19 first wave cohort
(pregnancies from 1 March
to 30 June 2020)
Neonatal outcomes5 n % of live
born babies
n % of live
born babies
Sex of baby
Male 36 767 51.3 25 074 51.3
Female 34 917 48.7 23 836 48.7
Birthweight
<1000 g 249 0.3 117 0.2
1000–1499 g 369 0.5 220 0.4
1500–2499 g 3620 5.0 2533 5.2
2500–4499 g 59533 83.0 43 751 89.5
>4500 g 1190 1.7 870 1.8
Unknown 6723 9.4 1419 2.9
Neonatal death
Early neonatal death (0–6 days) 101 0.14 58 0.12
Late neonatal death (7–27 days) 49 0.07 28 0.06
Survived neonatal period 71 534 99.8 48 824 99.8
1Age <10 or 55 classified as unknown.
2People with one or more of the following conditions indicate inclusion on the Scottish shielding list: solid organ transplant, specific cancers, severe respiratory
conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD), rare diseases and inborn errors of metabolism
that significantly increase the risk of infections (such as severe combined immunodeficiency [SCID], homozygous sickle cell disease), immunosuppression therapies
sufficient to significantly increase risk of infection, pregnant with significant heart disease, congenital or acquired, other clinical indication.
3People with one or more of the following comorbidities that are associated with severe COVID-19 outcomes in the general adult population (based on Q-
COVID29) and/or pregnant women specifically3 and are reasonably prevalent (>0.5%) among women of reproductive age in Scotland (as identified using EAVE
II data17): asthma, congenital heart disease, renal failure [chronic kidney disease (CKD)3, CKD4, CKD5, with or without dialysis or transplant], epilepsy, type 1
diabetes, type 2 diabetes, rheumatoid arthritis or systemic lupus erythematosus, venous thromboembolism, severe mental illness, body mass index (BMI) 40 kg/m2,
hypertension (based on read coded diagnosis within general practioner record), any other comorbidity included in the Q-COVID algorithm that is available
through the EAVE II GP dataset [chronic obstructive pulmonary disease, rare respiratory conditions (cystic fibrosis, bronchiectasis or alveolitis), pulmonary hy-
pertension or pulmonary fibrosis, coronary heart disease, atrial fibrillation, heart failure, stroke, peripheral vascular disease, cirrhosis, cerebral palsy, Parkinson’s
disease, rare neurological conditions (motor neurone disease, multiple sclerosis, myasthenia, Huntington’s chorea), dementia, blood cancer, lung or oral cancer,
sickle cell disease, osteoporotic fracture]
4Includes molar pregnancy.
5The following neonatal characteristics are also available: SIMD deprivation quintile; ethnicity; NHS Board Of Residence; urban/rural classification.
Figure 2 Gestational age of pregnant women on 1 March 2020 (a) and conceptions each month from 1 March 2020 onwards (b)
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characteristics, pregnancy and selected neonatal outcomes
of the participants in the dynamic cohort to 16 September
2021 and the COVID-19 first wave cohort are shown in
Table 2.
The COPS cohort has been linked to COVID-19 vacci-
nation data which show the changing pattern of uptake of
COVID-19 vaccinations by pregnant women.38
What are the main strengths and
weaknesses?
To our knowledge, this is the first near complete popula-
tion-level platform capturing all pregnancy outcomes from
conception to the end of the puerperium and neonatal pe-
riod. Linkage of GP records to established birth records
and secondary care records has allowed early pregnancy
losses to be included. This linkage has enriched the cohort
by identifying 4208 early pregnancy outcomes that are not
captured in secondary care records. Linkage to other data-
sets allows capture of rich data on maternal demographics
and comorbidities, COVID-19 disease and COVID-19 vac-
cination. The potential for future linkage to long-term
child and maternal health care data and primary and sec-
ondary care prescription data enables a robust platform
for future pharmacoepidemiology studies.
Weaknesses of the cohort include the fact that women
with early pregnancy loss who do not seek medical advice
will not be included. In addition, clinical maternity data on
a proportion of home births (which make up <2% of
births overall in Scotland) will not be available, although
the births themselves will be included. Although a key
strength is that we have population-based data on all
women with confirmed or probable COVID-19 in preg-
nancy, and are not restricted to women and babies
admitted to hospital, we acknowledge that restriction of vi-
ral PCR testing early in the pandemic to health care work-
ers and patients ill enough to require hospital admission,
may have limited ascertainment of all cases at that
time.39,40
Can I get hold of the data? Where can I find
out more?
The data underlying this article cannot be shared publicly
as they are sensitive. Public Health Scotland and the Chief
Medical Officer for Scotland are the data holders for the
data used in this study. Data are available to researchers
for analysis after securing relevant permissions from the
data holders. Enquiries regarding data availability should
be directed to [phs.edris@phs.scot].
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Figure 3 Pregnancy outcomes of the dynamic cohort by month of conception as of mid-September 2021
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